Abstract 4608: GSK5471713: A novel, selective oral androgen receptor degrader with best-in-class potential for the treatment of prostate cancer
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Christine Thompson, Yang Lee, Melissa C. Musso, Kwok-Ho Chan, Kamelia Behnia, Edward Hooper-Greenhill, Christian S. Sherk, Nanhua Deng, Nadeesha Rajapaksha, Mansi Babbar, Sarah Gerhart, Julie Bullock, Kenneth W. Hance, Benjamin Schwartz, Laure Rittié, Christopher P. Tinworth, Anastasia Wyce
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148724260
Cites:
Cited by:
Related to: